Endo Names Cooke to Board of Directors [Health & Beauty Close - Up]
(Health & Beauty Close - Up Via Acquire Media NewsEdge) Endo International reported the appointment of Shane M. Cooke to the company's board of directors.
According to a media release, Cooke, an international business leader with more than 25 years of experience, currently serves as president of Alkermes plc based in Dublin, Ireland. Cooke has also been appointed to Endo's Audit and Transactions Committee.
"I am excited to welcome Shane to our board of directors," said Roger Kimmel, chairman of the board of Endo. "He brings exceptional experience in the areas of finance, biotechnology as well as pharmaceutical operations. Our board is looking forward to the perspective Shane will provide related to our strategy and business operations as we continue to focus on delivering value for our customers and shareholders."
Endo International said Cooke joined Alkermes as president upon completion of the merger between Elan Drug Technologies (EDT) and Alkermes in September 2011. Previously, he was head of EDT and executive vice president of Elan from 2007 through the merger in 2011 and concurrently served as chief financial officer of Elan from 2001 to May 2011.
Cooke was appointed director of Elan in May 2005. Prior to joining Elan, he was chief executive of Pembroke Capital Limited, an aviation leasing company of which he was a founder.
Cooke is a chartered accountant. He currently serves on the board of directors of Prothena Corp. plc.
Endo International is a global specialty healthcare company.
((Comments on this story may be sent to email@example.com))
(c) 2014 ProQuest Information and Learning Company; All Rights Reserved.
[ Back To Cloud Contact Center's Homepage ]